ATOS Atossa Genetics Inc

Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

$2.01  +0.08 (4.15%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/08/2012
Outstanding shares:  126,624,110
Average volume:  3,512,650
Market cap:   $244,384,532
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04962H506
ISIN:        US04962H5063
Sedol:      BFXZQW0

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.81
PS ratio:   0.00
Return on equity:   -23.77%
Net income %:   0.00%